Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

Figure 2

Comparison of the frequency of loss of heterozygosity (LOH) at seven different polymorphic microsatellite markers detected in tumor tissues, blood and bone marrow samples from patients with primary (M0) and metastatic (M1) breast cancer. The frequency of LOH was calculated by division of the number of LOHs with the informative cases for each locus.

Back to article page